Shijia Zhang, MD, PhD Joins Florida Cancer Specialists & Research Institute

FCS Cancer Team Grows in Hillsborough County

FORT MYERS, Fla., Feb. 3, 2025 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome board-certified medical oncologist and hematologist Shijia Zhang, MD, PhD to the statewide practice. Dr. Zhang is providing care to patients at the FCS Brandon Cancer Center and FCS Sun City Center locations.

"Throughout his career, Dr. Zhang has received recognition for clinical excellence and his passion for contributing to cutting-edge advancements. We are very pleased to welcome him to our team of cancer experts in Hillsborough County," said FCS Chief Executive Officer Nathan H. Walcker.

Dr. Zhang earned his medical degree from Tongji University School of Medicine and a doctorate in biomedical sciences from Tulane University School of Medicine in New Orleans, Louisiana. He completed an internal medicine residency at Rutgers New Jersey Medical School in Newark, followed by a hematology and medical oncology fellowship at the University of Minnesota in Minneapolis.

FCS Assistant Managing Physician David Wenk, MD said, "Dr. Zhang is a highly-trained physician and experienced medical researcher, recognized for his numerous publications. He will provide his patients with the most advanced and promising treatments to achieve their best outcomes." 

As Hillsborough continues to grow, Dr. Zhang's contributions will play a vital role in meeting the growing oncology care demands of the expanding population.

About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its robust clinical research program.

FCS provides patients with access to a wide range of clinical trials, positioning it as a leader in research among private oncology practices in Florida and across the country. In fact, before receiving FDA approval, the majority of new cancer drugs in the U.S. were first made available to patients through participation in clinical trials at FCS.

Our outstanding team of highly trained and dedicated physicians is committed to delivering tailored treatment plans that make the best use of cutting-edge precision oncology advancements to enhance patient outcomes.

View original content to download multimedia:https://www.prnewswire.com/news-releases/shijia-zhang-md-phd-joins-florida-cancer-specialists--research-institute-302366801.html

SOURCE Florida Cancer Specialists & Research Institute